Webseiten-Bericht für lifescivc.com
LifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.LifeSciVC | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Generiert am 27 März 2026 06:27 AM
Aktuelle Statistiken? UPDATE !
Der Wert ist 54/100
SEO Inhalte
Seitentitel
LifeSciVC - Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.LifeSciVC | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Länge : 188
Ideal, aber Ihre Seitentitel sollte zwischen 10 und 70 Zeichen (Leerzeichen inbegriffen) enthalten. Benutzen Sie dieses kostenlose Werkzeug um die Länge zu prüfen.
Seitenbeschreibung
Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech.
Länge : 82
Großartig, denn Ihre Seitenbeschreibung enthält zwischen 70 und 160 Anzahl Zeichen.
Suchbegriffe
Nicht so gut. Wir konnten keine META-Suchbegriffe auf Ihrer Webseite finden. Benutzen Sie dieses kostenlose Werkzeug um META-Suchbegriffe zu erzeugen.
Og META Eigenschaften
Sehr gut, denn diese Webseite nutzt die Vorteile aus den Og Properties.
| Eigenschaft | Inhalt |
|---|---|
| locale | en_US |
| type | website |
| title | LifeSciVC |
| description | Bruce Booth, partner at Atlas Venture, blogs on all facets of early stage biotech. |
| url | https://lifescivc.com/ |
| site_name | LifeSciVC |
Überschriften
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 40 | 7 | 0 | 0 | 0 |
- [H1] Process-Driven Cadence: Biotech IPOs Demystified
- [H1] Atlas Venture 2025 Year In Review
- [H2] Twenty Years In Early Stage Biotech VC (Part 3): BusinessOctober 16, 2025
- [H2] Twenty Years In Early Stage Biotech VC (Part 2): PeopleOctober 15, 2025
- [H2] Twenty Years In Early Stage Biotech VC (Part 1): ScienceOctober 14, 2025
- [H2] Biotech Wisdom Of The Crowds: Competition And CapitalismMay 28, 2025
- [H2] Biotech Venture Creation: The Benefits Of ScarcityApril 8, 2025
- [H2] Atlas XIV And Reflections On The VC Math ProblemDecember 5, 2024
- [H2] Atlas Venture 2024 Year In ReviewNovember 18, 2024
- [H2] Biotech Risk Cycles: Assets And PlatformsOctober 28, 2024
- [H2] A Molecular Biologist’s Advice For LifeJuly 1, 2024
- [H2] Mariana Oncology’s Radiopharm Platform Acquired By NovartisMay 6, 2024
- [H2] The Biotech Startup Contraction Continues… And That’s A Good ThingApril 26, 2024
- [H2] IFM’s Hat Trick and Reflections On Option-To-Buy M&AMarch 13, 2024
- [H2] Biotech Venture Ecosystem: Quick Health CheckJanuary 12, 2024
- [H2] Biotech Consolidation: Not Really HappeningNovember 30, 2023
- [H2] Atlas Venture 2023 Year In ReviewNovember 17, 2023
- [H2] Biotech Funding: Times Are Tough, Maybe For The BetterApril 14, 2023
- [H2] Science2Startup 2023: Innovation And EntrepreneurshipFebruary 28, 2023
- [H2] Takeda Acquires Nimbus’ Tyk2 Autoimmune ProgramDecember 13, 2022
- [H2] Atlas Venture 2022 Year In ReviewNovember 7, 2022
- [H2] Surprising Resilience Of Private VC-Backed Biotech MarketsJuly 6, 2022
- [H2] Responding To Tough Markets: Restructurings In BiotechApril 14, 2022
- [H2] Biotech’s January Chill: Big Drop In New StartupsApril 4, 2022
- [H2] In Defense Of Early Stage Biotech IPOsMarch 28, 2022
- [H2] Innovation Ecosystem: A Year Of Risk-Off CorrelationsMarch 21, 2022
- [H2] Biotech Bears: Jumping A Lower Bar Or A Higher One?March 17, 2022
- [H2] Getting Public Is Easy, Being Public Is HardNovember 18, 2021
- [H2] State of the Industry: 2021 Year In ReviewNovember 16, 2021
- [H2] Biotech’s Relevancy Challenge In An Expanding UniverseJune 1, 2021
- [H2] Five Macro Risks To Biotech Coming Out of WashingtonApril 22, 2021
- [H2] Biotech Funding Tops The Charts AgainApril 20, 2021
- [H2] Personal Reflection: Empathy In The WorkplaceMarch 16, 2021
- [H2] The Biotech Paradox of 2020: A Year In ReviewJanuary 4, 2021
- [H2] Biotech: The Featherweight Champion Of The MarketsNovember 20, 2020
- [H2] It’s Raining Biotech SPACs!October 15, 2020
- [H2] Evolution Of The Biotech IPO Markets From Busted To BoomingSeptember 21, 2020
- [H2] Kymera Debuts On The Public MarketsAugust 31, 2020
- [H2] The Record-Breaking Biotech Funding Tsunami Of 1H2020July 15, 2020
- [H2] Value Creation And Destruction: Dispersion of Performance In Biotech IPOsApril 17, 2020
- [H2] Booming VC-Backed Biopharma: Strong Market Despite PandemicApril 8, 2020
- [H2] Strategic Planning In Biotech During A Pandemic CrisisMarch 26, 2020
- [H3] search
- [H3] subscribe by email
- [H3] Twitter
- [H3] Recent Posts
- [H3] current comments
- [H3] topics
- [H3] monthly archive
Bilder
Es konnten 9 Bilder auf dieser Webseite gefunden werden.
Bei 3 Bilder(n) fehlt ein ALT-Attribut. Fügen Sie ALT-Attribute zu Ihren Bildern, um die Bedeutung der Bilder für Suchmaschinen zugänglich zu machen.
Text/HTML Verhältnis
Anteil : 17%
Gut, denn das Text zu HTML Code Verhältnis dieser Webseite ist höher als 15, aber niedriger als 25 Prozent.
Flash
Perfekt, denn es wurde kein Flash auf Ihrer Webseite gefunden.
IFrame
Großartig, denn Sie verwenden keine IFrames auf Ihrer Webseite.
SEO Links
URL Rewrite
Gut. Ihre Links sind für Suchmaschinen gut lesbar (sprechende Links)!
Underscores in the URLs
Wir haben Unterstriche in Ihren Links entdeckt. Benutzen Sie zur Optimierung besser Bindestriche in Ihren Links.
In-page links
We found a total of 289 links including 0 link(s) to files
| Anker | Typ | Natürlich |
|---|---|---|
| Blog | intern | natürliche Links |
| About Me | intern | natürliche Links |
| From The Trenches | intern | natürliche Links |
| Process-Driven Cadence: Biotech IPOs Demystified | intern | natürliche Links |
| Capital markets | intern | natürliche Links |
| Exits IPOs M&As | intern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| how fundamentally it changed the IPO process | intern | natürliche Links |
| Comment | intern | natürliche Links |
| Atlas Venture 2025 Year In Review | intern | natürliche Links |
| Atlas Venture | intern | natürliche Links |
| Biotech financing | intern | natürliche Links |
| Drug discovery | intern | natürliche Links |
| Pharma industry | intern | natürliche Links |
| Pricing and Policy | intern | natürliche Links |
| R&D Productivity | intern | natürliche Links |
| Science & Medicine | intern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| - | extern | natürliche Links |
| 2024 | intern | natürliche Links |
| 2023 | intern | natürliche Links |
| 2022 | intern | natürliche Links |
| 2021 | intern | natürliche Links |
| 2020 | intern | natürliche Links |
| 2019 | intern | natürliche Links |
| 2018 | intern | natürliche Links |
| Comment | intern | natürliche Links |
| Twenty Years In Early Stage Biotech VC (Part 3): Business | intern | natürliche Links |
| Twenty Years In Early Stage Biotech VC (Part 2): People | intern | natürliche Links |
| Twenty Years In Early Stage Biotech VC (Part 1): Science | intern | natürliche Links |
| Biotech Wisdom Of The Crowds: Competition And Capitalism | intern | natürliche Links |
| Biotech Venture Creation: The Benefits Of Scarcity | intern | natürliche Links |
| Atlas XIV And Reflections On The VC Math Problem | intern | natürliche Links |
| Biotech Risk Cycles: Assets And Platforms | intern | natürliche Links |
| A Molecular Biologist’s Advice For Life | intern | natürliche Links |
| Mariana Oncology’s Radiopharm Platform Acquired By Novartis | intern | natürliche Links |
| The Biotech Startup Contraction Continues… And That’s A Good Thing | intern | natürliche Links |
| IFM’s Hat Trick and Reflections On Option-To-Buy M&A | intern | natürliche Links |
| Biotech Venture Ecosystem: Quick Health Check | intern | natürliche Links |
| Biotech Consolidation: Not Really Happening | intern | natürliche Links |
| Biotech Funding: Times Are Tough, Maybe For The Better | intern | natürliche Links |
| Science2Startup 2023: Innovation And Entrepreneurship | intern | natürliche Links |
| Takeda Acquires Nimbus’ Tyk2 Autoimmune Program | intern | natürliche Links |
| Surprising Resilience Of Private VC-Backed Biotech Markets | intern | natürliche Links |
| Responding To Tough Markets: Restructurings In Biotech | intern | natürliche Links |
| Biotech’s January Chill: Big Drop In New Startups | intern | natürliche Links |
| In Defense Of Early Stage Biotech IPOs | intern | natürliche Links |
| Innovation Ecosystem: A Year Of Risk-Off Correlations | intern | natürliche Links |
| Biotech Bears: Jumping A Lower Bar Or A Higher One? | intern | natürliche Links |
| Getting Public Is Easy, Being Public Is Hard | intern | natürliche Links |
| Biotech’s Relevancy Challenge In An Expanding Universe | intern | natürliche Links |
| Five Macro Risks To Biotech Coming Out of Washington | intern | natürliche Links |
| Biotech Funding Tops The Charts Again | intern | natürliche Links |
| Personal Reflection: Empathy In The Workplace | intern | natürliche Links |
| Biotech: The Featherweight Champion Of The Markets | intern | natürliche Links |
| It’s Raining Biotech SPACs! | intern | natürliche Links |
| Kymera Debuts On The Public Markets | intern | natürliche Links |
| The Record-Breaking Biotech Funding Tsunami Of 1H2020 | intern | natürliche Links |
| Value Creation And Destruction: Dispersion of Performance In Biotech IPOs | intern | natürliche Links |
| Booming VC-Backed Biopharma: Strong Market Despite Pandemic | intern | natürliche Links |
| Strategic Planning In Biotech During A Pandemic Crisis | intern | natürliche Links |
| Tweets by @LifeSciVC | extern | natürliche Links |
| Balancing the Risks and Rewards of Drug Development in China: A Small Biotech CEO Perspective | intern | natürliche Links |
| Ex-US Clinical Trials: Tribulations, Preparations, and Expectations | intern | natürliche Links |
| Dual Wielding in I&I: A Pivotal Year Ahead | intern | natürliche Links |
| Why Owning the Learning Loop Matters More Than Owning the Lab | intern | natürliche Links |
| Two’s Company, Three’s Diversity | intern | natürliche Links |
| Two’s Company, Three’s Diversity | intern | natürliche Links |
| AliFarquhar | extern | natürliche Links |
| Two’s Company, Three’s Diversity | intern | natürliche Links |
| When Does Digital Health Become Just Healthcare? | intern | natürliche Links |
| We Saw It Coming In Pharma: Now Gene Therapy Is Biotech 2.0 For Rare Diseases | intern | natürliche Links |
| #RunningAtlas | intern | natürliche Links |
| Adaptive Sports | intern | natürliche Links |
| Bioentrepreneurship | intern | natürliche Links |
| Biotech investment themes | intern | natürliche Links |
| Biotech startup advice | intern | natürliche Links |
| Boards and governance | intern | natürliche Links |
| Boston Cluster | intern | natürliche Links |
| Business Development | intern | natürliche Links |
| Capital efficiency | intern | natürliche Links |
| China | intern | natürliche Links |
| Corporate Culture | intern | natürliche Links |
| Diagnostics | intern | natürliche Links |
| External R&D | intern | natürliche Links |
| FDA | intern | natürliche Links |
| From The Trenches | intern | natürliche Links |
| Fundraising | intern | natürliche Links |
| General Venture Capital | intern | natürliche Links |
| Governance | intern | natürliche Links |
| Leadership | intern | natürliche Links |
| Marketing | intern | natürliche Links |
| New business models | intern | natürliche Links |
| Patients | intern | natürliche Links |
| Personal | intern | natürliche Links |
| Personalized Medicine | intern | natürliche Links |
| Portfolio news | intern | natürliche Links |
| Rare Diseases | intern | natürliche Links |
| Strategy | intern | natürliche Links |
| Talent | intern | natürliche Links |
| The Human Element | intern | natürliche Links |
| Translational research | intern | natürliche Links |
| Uncategorized | intern | natürliche Links |
| VC-backed Biotech Returns | intern | natürliche Links |
| March 2026 | intern | natürliche Links |
| February 2026 | intern | natürliche Links |
| January 2026 | intern | natürliche Links |
| December 2025 | intern | natürliche Links |
| November 2025 | intern | natürliche Links |
| October 2025 | intern | natürliche Links |
| September 2025 | intern | natürliche Links |
| August 2025 | intern | natürliche Links |
| July 2025 | intern | natürliche Links |
| June 2025 | intern | natürliche Links |
| May 2025 | intern | natürliche Links |
| April 2025 | intern | natürliche Links |
| March 2025 | intern | natürliche Links |
| February 2025 | intern | natürliche Links |
| January 2025 | intern | natürliche Links |
| December 2024 | intern | natürliche Links |
| November 2024 | intern | natürliche Links |
| October 2024 | intern | natürliche Links |
| September 2024 | intern | natürliche Links |
| August 2024 | intern | natürliche Links |
| July 2024 | intern | natürliche Links |
| June 2024 | intern | natürliche Links |
| May 2024 | intern | natürliche Links |
| April 2024 | intern | natürliche Links |
| March 2024 | intern | natürliche Links |
| February 2024 | intern | natürliche Links |
| January 2024 | intern | natürliche Links |
| November 2023 | intern | natürliche Links |
| October 2023 | intern | natürliche Links |
| September 2023 | intern | natürliche Links |
| August 2023 | intern | natürliche Links |
| July 2023 | intern | natürliche Links |
| June 2023 | intern | natürliche Links |
| May 2023 | intern | natürliche Links |
| April 2023 | intern | natürliche Links |
| March 2023 | intern | natürliche Links |
| February 2023 | intern | natürliche Links |
| January 2023 | intern | natürliche Links |
| December 2022 | intern | natürliche Links |
| November 2022 | intern | natürliche Links |
| October 2022 | intern | natürliche Links |
| September 2022 | intern | natürliche Links |
| August 2022 | intern | natürliche Links |
| July 2022 | intern | natürliche Links |
| June 2022 | intern | natürliche Links |
| May 2022 | intern | natürliche Links |
| April 2022 | intern | natürliche Links |
| March 2022 | intern | natürliche Links |
| February 2022 | intern | natürliche Links |
| January 2022 | intern | natürliche Links |
| November 2021 | intern | natürliche Links |
| October 2021 | intern | natürliche Links |
| September 2021 | intern | natürliche Links |
| August 2021 | intern | natürliche Links |
| July 2021 | intern | natürliche Links |
| June 2021 | intern | natürliche Links |
| May 2021 | intern | natürliche Links |
| April 2021 | intern | natürliche Links |
| March 2021 | intern | natürliche Links |
| January 2021 | intern | natürliche Links |
| December 2020 | intern | natürliche Links |
| November 2020 | intern | natürliche Links |
| October 2020 | intern | natürliche Links |
| September 2020 | intern | natürliche Links |
| August 2020 | intern | natürliche Links |
| July 2020 | intern | natürliche Links |
| June 2020 | intern | natürliche Links |
| May 2020 | intern | natürliche Links |
| April 2020 | intern | natürliche Links |
| March 2020 | intern | natürliche Links |
| February 2020 | intern | natürliche Links |
| January 2020 | intern | natürliche Links |
| December 2019 | intern | natürliche Links |
| November 2019 | intern | natürliche Links |
| October 2019 | intern | natürliche Links |
| September 2019 | intern | natürliche Links |
| August 2019 | intern | natürliche Links |
| July 2019 | intern | natürliche Links |
| May 2019 | intern | natürliche Links |
| April 2019 | intern | natürliche Links |
| March 2019 | intern | natürliche Links |
| February 2019 | intern | natürliche Links |
| January 2019 | intern | natürliche Links |
| December 2018 | intern | natürliche Links |
| November 2018 | intern | natürliche Links |
| October 2018 | intern | natürliche Links |
| September 2018 | intern | natürliche Links |
| August 2018 | intern | natürliche Links |
| July 2018 | intern | natürliche Links |
| June 2018 | intern | natürliche Links |
| May 2018 | intern | natürliche Links |
| April 2018 | intern | natürliche Links |
| March 2018 | intern | natürliche Links |
| February 2018 | intern | natürliche Links |
| January 2018 | intern | natürliche Links |
| December 2017 | intern | natürliche Links |
| November 2017 | intern | natürliche Links |
| October 2017 | intern | natürliche Links |
| September 2017 | intern | natürliche Links |
| August 2017 | intern | natürliche Links |
| July 2017 | intern | natürliche Links |
| June 2017 | intern | natürliche Links |
| May 2017 | intern | natürliche Links |
| April 2017 | intern | natürliche Links |
| March 2017 | intern | natürliche Links |
| February 2017 | intern | natürliche Links |
| January 2017 | intern | natürliche Links |
| December 2016 | intern | natürliche Links |
| November 2016 | intern | natürliche Links |
| October 2016 | intern | natürliche Links |
| September 2016 | intern | natürliche Links |
| August 2016 | intern | natürliche Links |
| July 2016 | intern | natürliche Links |
| June 2016 | intern | natürliche Links |
| May 2016 | intern | natürliche Links |
| April 2016 | intern | natürliche Links |
| March 2016 | intern | natürliche Links |
| February 2016 | intern | natürliche Links |
| January 2016 | intern | natürliche Links |
| December 2015 | intern | natürliche Links |
| November 2015 | intern | natürliche Links |
| October 2015 | intern | natürliche Links |
| September 2015 | intern | natürliche Links |
| August 2015 | intern | natürliche Links |
| July 2015 | intern | natürliche Links |
| June 2015 | intern | natürliche Links |
| May 2015 | intern | natürliche Links |
| April 2015 | intern | natürliche Links |
| March 2015 | intern | natürliche Links |
| February 2015 | intern | natürliche Links |
| January 2015 | intern | natürliche Links |
| December 2014 | intern | natürliche Links |
| November 2014 | intern | natürliche Links |
| October 2014 | intern | natürliche Links |
| September 2014 | intern | natürliche Links |
| August 2014 | intern | natürliche Links |
| July 2014 | intern | natürliche Links |
| June 2014 | intern | natürliche Links |
| May 2014 | intern | natürliche Links |
| April 2014 | intern | natürliche Links |
| March 2014 | intern | natürliche Links |
| February 2014 | intern | natürliche Links |
| January 2014 | intern | natürliche Links |
| December 2013 | intern | natürliche Links |
| November 2013 | intern | natürliche Links |
| October 2013 | intern | natürliche Links |
| September 2013 | intern | natürliche Links |
| August 2013 | intern | natürliche Links |
| July 2013 | intern | natürliche Links |
| June 2013 | intern | natürliche Links |
| May 2013 | intern | natürliche Links |
| April 2013 | intern | natürliche Links |
| March 2013 | intern | natürliche Links |
| February 2013 | intern | natürliche Links |
| January 2013 | intern | natürliche Links |
| December 2012 | intern | natürliche Links |
| November 2012 | intern | natürliche Links |
| October 2012 | intern | natürliche Links |
| September 2012 | intern | natürliche Links |
| August 2012 | intern | natürliche Links |
| July 2012 | intern | natürliche Links |
| June 2012 | intern | natürliche Links |
| May 2012 | intern | natürliche Links |
| April 2012 | intern | natürliche Links |
| March 2012 | intern | natürliche Links |
| February 2012 | intern | natürliche Links |
| January 2012 | intern | natürliche Links |
| December 2011 | intern | natürliche Links |
| November 2011 | intern | natürliche Links |
| October 2011 | intern | natürliche Links |
| September 2011 | intern | natürliche Links |
| August 2011 | intern | natürliche Links |
| July 2011 | intern | natürliche Links |
| June 2011 | intern | natürliche Links |
| May 2011 | intern | natürliche Links |
| April 2011 | intern | natürliche Links |
| March 2011 | intern | natürliche Links |
| Privacy Policy | intern | natürliche Links |
SEO Suchbegriffe
Suchbegriffswolke
ipo january november venture comment march leave year biotech april
Keywords Consistency
| Suchbegriff | Inhalt | Seitentitel | Suchbegriffe | Seitenbeschreibung | Überschriften |
|---|---|---|---|---|---|
| biotech | 42 |  |
 |
|
|
| ipo | 28 | |
|
|
|
| comment | 22 | |
|
|
|
| leave | 22 | |
|
|
|
| april | 21 | |
|
|
|
Benutzerfreundlichkeit
URL
Domain : lifescivc.com
Länge : 13
Favoriten Icon
Gut. Die Webseite hat ein Favicon.
Druckeigenschaften
Es konnten keine druckfreundlichen CSS-Angaben gefunden werden.
Sprache
Gut, denn Sie haben in den META-Elementen eine Sprache deklariert: en.
Dublin Core
Diese Webseite nutzt nicht die Vorteile der Dublin Core Elemente.
Dokument
Doctype
HTML 5
Verschlüsselung
Perfekt, denn Ihre Webseite deklariert einen Zeichensatz: UTF-8.
W3C Validität
Fehler : 0
Warnungen : 0
E-Mail Datenschutz
Achtung! Es wurde mindestens eine E-Mail Adresse im Klartext auf Ihrer Webseite gefunden. Benutzen Sie dieses kostenlose Werkzeug um E-Mail Adressen vor SPAM zu schützen.
Veraltetes HTML
Sehr gut! Sie verwenden aktuelle HTML Tags in Ihrem Webseitenquelltext.
Tipps zur Webseitengeschwindigkeit
|
Sehr gut, denn Ihre Webseite benutzt keine verschachtelten Tabellen. |
|
Schlecht, denn es wurden CSS-Angaben in HTML-Elementen entdeckt. Diese Angaben sollten in ein entsprechendes CSS-Stylesheet verlagert werden. |
|
Nicht so gut, denn Ihre Webseite enthält sehr viele CSS-Dateien (mehr als 4). |
|
Nicht so gut, denn Ihre Webseite enthält viele Javascript-Dateien (mehr als 6). |
|
Gut! Sie nutzen die Vorteile von gzip. |
Mobile
Mobile Optimierung
|
Apple Icon |
|
META Viewport Tag |
|
Flash Inhalt |
Optimierung
XML-Sitemap
Perfekt! Ihre Seite hat eine XML-Sitemap.
| https://lifescivc.com/sitemap_index.xml |
Robots.txt
https://lifescivc.com/robots.txt
Sehr gut! Ihre Webseite enthält eine robots.txt-Datei.
Analytics
Sehr gut, Ihre Website hat ein Analyse-Tool.
Google Analytics |
PageSpeed Insights
Gerät
Kategorien
Free SEO Testing Tool
Free SEO Testing Tool ist ein kostenloses SEO Werkzeug zur Analyse Ihrer Webseite